Description
CLINICAL USE:
- Identifying asymptomatic individuals at greater risk for developing Alzheimer’s disease or other neurological disorder.
- Identifying reactivity to triggers of Alzheimer’s disease or other neurological disorder.
- Identifying the early stages of neurodegenerative processes.
- Monitoring the effectiveness of lifestyle modifications for Alzheimer’s disease.
- Are interested in preventing the development of Alzheimer’s disease or other neurological disorder.
- Are exhibiting early signs of Alzheimer’s disease or other neurological disorder.
- Have been diagnosed with Alzheimer’s disease.
- Have a history of gastrointestinal disorders and/or diabetes.
- Played high-impact sports.
- Are immunoreactive against specific pathogens, chemicals and foods.
